Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.32% |
| 2 | Healthcare | 13.34% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESSA
3626
DELISTED
ESSA Bancorp
ESSA
| $609K | ﹤0.01% |
36,951
-204
| -0.5% | -$3.38K |
|
|
TIG
3627
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $609K | ﹤0.01% |
58,841
+3,817
| +7% | +$45.4K |
|
|
QTNT
3628
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $609K | ﹤0.01% |
6,495
+130
| +2% | +$16.2K |
|
|
TRVN
3629
DELISTED
Trevena, Inc.
TRVN
| $608K | ﹤0.01% |
791
-7
| -0.9% | -$5.94K |
|
3630
Comp X International
CIX
$390M
| $607K | ﹤0.01% |
29,224
-9,158
| -24% | -$194K |
|
3631
Eastern Company
EML
$154M
| $607K | ﹤0.01% |
24,130
-200
| -0.8% | -$5.58K |
|
|
DZSI
3632
DELISTED
DZS Inc. Common Stock
DZSI
| $607K | ﹤0.01% |
49,511
+7,396
| +18% | +$116K |
|
3633
Tonix Pharmaceuticals
TNXP
$214M
| $603K | ﹤0.01% |
2
| – | – |
|
|
CSLT
3634
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $602K | ﹤0.01% |
383,459
+41,749
| +12% | +$81.8K |
|
|
FONR
3635
DELISTED
Fonar
FONR
| $601K | ﹤0.01% |
38,837
-204
| -0.5% | -$3.46K |
|
3636
State Street SPDR S&P Bank ETF
KBE
$1.75B
| $601K | ﹤0.01% |
11,351
-961
| -8% | -$48.8K |
|
3637
AgEagle Aerial Systems
UAVS
$62.7M
| $601K | ﹤0.01% |
200
+14
| +8% | +$52K |
|
|
ETNB
3638
DELISTED
89bio
ETNB
| $600K | ﹤0.01% |
30,659
+2,112
| +7% | +$38.6K |
|
3639
inTEST
INTT
$174M
| $599K | ﹤0.01% |
52,117
| – | – |
|
|
CDAK
3640
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $598K | ﹤0.01% |
36,637
+5,233
| +17% | +$93.6K |
|
|
MYOV
3641
DELISTED
Myovant Sciences Ltd.
MYOV
| $597K | ﹤0.01% |
26,583
+4,800
| +22% | +$105K |
|
3642
FS KKR Capital
FSK
$3.49B
| $594K | ﹤0.01% |
26,920
+9,432
| +54% | +$208K |
|
3643
Invesco Water Resources ETF
PHO
$2.06B
| $594K | ﹤0.01% |
10,842
+3,001
| +38% | +$170K |
|
3644
Concrete Pumping Holdings
BBCP
$475M
| $593K | ﹤0.01% |
69,518
+5,588
| +9% | +$47K |
|
3645
Nature's Sunshine
NATR
$269M
| $591K | ﹤0.01% |
40,306
+3,968
| +11% | +$66.6K |
|
3646
Edgewise Therapeutics
EWTX
$4.69B
| $588K | ﹤0.01% |
35,414
+6,941
| +24% | +$126K |
|
3647
Thryv Holdings
THRY
$96.9M
| $588K | ﹤0.01% |
19,574
+8,099
| +71% | +$254K |
|
|
SEEL
3648
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $588K | ﹤0.01% |
64
+19
| +42% | +$163K |
|
|
BFIN
3649
DELISTED
BankFinancial
BFIN
| $584K | ﹤0.01% |
50,888
-26,237
| -34% | -$298K |
|
3650
C&F Financial
CFFI
$288M
| $583K | ﹤0.01% |
10,980
+3,331
| +44% | +$174K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.